Influenza cases are on the rise across Australia, and health officials are gearing up for a challenging peak flu season. Hospitals are seeing a spike in admissions, leading to urgent calls for the public to stay alert and get vaccinated to help slow the spread of this virus.
An Indian drugmaker, once under the microscope of ProPublica, has announced a recall of two dozen medications that were sent to patients across the U.S. This alarming development has sparked fresh concerns about the safety and quality of drugs, especially in light of previous investigations that uncovered troubling issues within the company.
Eli Lilly’s recent launch of Mounjaro in India has sparked a surge in inquiries about weight-loss solutions. The new drug, aimed at managing obesity, has captured significant attention, reflecting a growing demand for effective weight management options in the country.
Canada has added a commonly prescribed blood pressure medication to its drug shortages website, raising concerns among healthcare professionals about potential impacts on patient care. Authorities urge patients to consult with their physicians for alternatives.
Former Brazilian President Jair Bolsonaro has been hospitalized due to abdominal pain, according to reports. The 68-year-old, who has a history of health issues following a stabbing in 2018, is undergoing tests to determine the cause of his discomfort.
bioMérieux has announced that it has received Health Canada approval for its BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel. This diagnostic tool aims to enhance rapid testing for respiratory infections, providing efficient solutions for patient care in Canada.
